QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2016    内容类型：会议论文    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 In Vivo Study on Re-oxygenation of Tumor after Heavy Carbon-Ion Beam and Photon Beam Irradiation Using animal F-18-MISO PETCT 会议论文 作者:  Cheng, J.;  Lu, J.;  Sheng, Y.;  Jiang, Z.;  Li, Z. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 CA19-9 as a Prognostic Biomarker in Pancreatic Neuroendocrine Tumors 会议论文 作者:  Luo, G.;  Guo, M.;  Liu, Z.;  Liu, C.;  Cheng, H. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 pNET  Prognosis  CA19-9  Biomarker   Neutrophil-Lymphocyte Ratio Predicts Survival in Pancreatic Neuroendocrine Tumors 会议论文 作者:  Luo, G.;  Jin, K.;  Liu, C.;  Lu, Y.;  Cheng, H. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 pNET  Prognosis  Pancreatic neuroendocrine tumor  NLR   HYPERTENSION IN CHINESE PATIENTS WITH CHRONIC KIDNEY DISEASE: PREVALENCE, MANAGEMENT AND PHARMACOEPIDEMIOLOGY 会议论文 作者:  Zhang, W.;  Shi, W.;  Liu, Z.;  Gu, Y.;  Chen, Q. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Expression of Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Neoplasm and Multicenter Retrospective Clinical Study of Octreotide LAR in the Treatment of Advanced GEP-NET 会议论文 作者:  Yuhong, W.;  Wei, W.;  Kaizhou, J.;  Cheng, F.;  Zhiwei, Z. 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Gastroenteropancreatic neuroendocrine neoplasm  somatostatin receptor  octreotide  treatment   Immune correlates of severe influenza disease in patients hospitalized with seasonal influenza viruses in Australia and with the novel avian H7N9 virus in China 会议论文 作者:  Nguyen, O.;  Wang, Z.;  Loh, L.;  Clemens, E. B.;  Sant, S. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 FIVE-YEAR ON-TREATMENT SYSTEMATICALLY MONITORING OF DYNAMIC CHANGES OF LIVER STIFFNESS MEASUREMENT WITH TRANSIENT ELASTOGRAPHY COMPARED WITH PAIRED LIVER BIOPSIES IN A RANDOMIZED CONTROLLED TRIAL IN CHRONIC HEPATITIS B PATIENTS 会议论文 作者:  Sun, J.;  Xie, Q.;  Tan, D.;  Ning, Q.;  Niu, J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/06 A PHASE II STUDY WITH ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER IN DEVELOPING COUNTRY: A SHANGHAI GYNECOLOGIC ONCOLOGY GROUP AICE TRIAL 会议论文 作者:  Zang, R.;  Jiang, R.;  Yu, J.;  Yang, H.;  Tu, D. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/06 ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER: The PRELIMINARY ANALYSIS OF A RANDOMIZED PHASE II STUDY 会议论文 作者:  Jiang, R.;  Yu, J.;  Dai, Z.;  Shen, Y.;  Zhang, Y. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/06